Neuropace, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Sep 2025Filed 04/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Sep 2024Filed 04/11/2025 | Jun 2024Filed 04/11/2025 | Mar 2024Filed 04/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $23 | $22 | $27 | $20 | $23 | $21 | $19 | $18 | |
| −$6.2 | −$6.7 | −$3.5 | −$8.7 | −$6.6 | −$5.5 | −$7.5 | −$8.9 | |
| −$0.18 | −$0.20 | −$0.11 | −$0.26 | −$0.21 | −$0.19 | −$0.26 | −$0.32 | |
| 34 | 34 | 33 | 33 | 31 | 29 | 29 | 28 |
Trend